retatrutide ly3437943 parkinson's disease clinical trial Meets Phase 3 Weight-Loss Endpoints in 2 Obesity Trials Help cure Parkinson's disease: please

While retatrutide has generally been well-tolerated, clinical trials have also revealed a dose-dependent pattern with GI side effects

See my full source hierarchy

Because the triple-receptor design distinguishes it from earlier single- and dual-agonist peptides, the published literature has grown along an unusually legible arc: a founding discovery paper, a structural-biology study resolving how one peptide can occupy three distinct receptor complexes, and a sequence of clinical trials that broadened from glycemic endpoints into obesity and liver-fat endpoints

This is not typically recommended, as clinical trials used once-weekly dosing

This chart shows clinical trial protocols and is for informational purposes only

Woah- those are a doozy